Figure 5
Figure 5. Analysis of mCG-PR+/− × Rara+/− and mCG-PR+/− × Rara +/+ leukemia cells. (A) Expression array profiling of leukemic spleen cells from 5 mCG-PR+/− × Rara+/− and 5 mCG-PR+/− × Rara+/+ mice using Affymetrix Exon 1.0 arrays. Tumors did not cluster by genotype using an unsupervised analysis. (B-D) Ex vivo ATRA sensitivity. (B) Experimental schema. (C) Cryopreserved spleen cells from 9 mCG-PR+/− × Rara+/− and 9 mCG-PR+/− × Rara+/+ independent tumors were thawed and cultured for 48 hours in liquid medium containing IL-3, IL-6, and SCF ± 1μM ATRA. Viable cells were counted and plated in methylcellulose containing IL-3, IL-6, and SCF. After 7 days, colonies (C) were counted and pairwise assessed for ATRA sensitivity (D).

Analysis of mCG-PR+/− × Rara+/− and mCG-PR+/− × Rara+/+ leukemia cells. (A) Expression array profiling of leukemic spleen cells from 5 mCG-PR+/− × Rara+/− and 5 mCG-PR+/− × Rara+/+ mice using Affymetrix Exon 1.0 arrays. Tumors did not cluster by genotype using an unsupervised analysis. (B-D) Ex vivo ATRA sensitivity. (B) Experimental schema. (C) Cryopreserved spleen cells from 9 mCG-PR+/− × Rara+/− and 9 mCG-PR+/− × Rara+/+ independent tumors were thawed and cultured for 48 hours in liquid medium containing IL-3, IL-6, and SCF ± 1μM ATRA. Viable cells were counted and plated in methylcellulose containing IL-3, IL-6, and SCF. After 7 days, colonies (C) were counted and pairwise assessed for ATRA sensitivity (D).

Close Modal

or Create an Account

Close Modal
Close Modal